News | News By Subject | News by Disease News By Date | Search News

Addiction News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
New Braeburn Pharma CEO Has Company on Track with Filing for Opioid Addiction Drug NDA     7/21/2017
First Time Ever: FDA Asks Endo Pharma (ENDP) to Stop Selling Opana ER Amid Opioid Crisis     6/9/2017
This Bay Area Biotech Snags $293 Million Pain Drug Pact With Novartis AG (NVS)     5/9/2017
How Alkermes (ALKS) Transformed an Anti-Addiction Drug From a Bust to a Hit     9/28/2016
How Abbott (ABT) and Its Sales Reps Quietly Played a Role in the OxyContin Epidemic     9/22/2016
Bay Area's Chrono Scores $47.6 Million for Wearable to Deliver Nicotine Fix Before Smokers Even Wake Up     9/8/2016
Indivior Shows Off Late-Stage Opiod Addiction Trial Data     8/17/2016
What Purdue Pharma L.P. Knew About a Oxycontin Ring that Pushed More than 1 Million Pills     7/11/2016
Mallinckrodt (MNK) Warned Over Missing Study About Child Opioids Use     7/8/2016
Titan Pharma (TTNP) Receives FDA Approval for the First Ever Implantable Device for Opioid Dependency     5/27/2016
Europe Lifts Warning on Pfizer (PFE)'s Smoking Cessation Drug Champix     5/23/2016
Braeburn Pharma, Camurus Announce Positive Mid-Stage CAM2038 Data in Patients With Opioid Use Disorder     5/11/2016
KemPharm (KMPH) Crashes After the FDA Votes Against Abuse-Deterrent Labeling for Pain Med     5/6/2016
Otsuka America Pharma's Abilify Can Cause Urges to Gamble, Eat, Shop, Have Sex: FDA     5/5/2016
No Suicide Risk Linked to Pfizer (PFE)'s Chantix     4/25/2016

News from Around the Web
Fake Painkillers Laced With A Legal Drug 50 Times Stronger Than Heroin     8/16/2017
How A High-Fat Diet In Childhood May Wire The Brain For Addiction, eNeuro Reveals     6/1/2017
Gray Death: The Most Powerful New Opioid Combo That's Risky Even To Touch     5/8/2017
A New Weapon In The War Against Opioid Abuse?     5/4/2017
The Life Of John Bravis, Medtronic (MDT)’s "Employee Number Three"     1/31/2017
This Small Biotech's $4,500 Injection Is Used To Stop Heroin Overdoses     1/30/2017
What Pot Really Does To Your Body And Brain     1/27/2017
Alcohol Flips Brain Into Hungry Mode, Francis Crick Institute Study     1/13/2017
Tech Devices To Treat Chronic Pain Could Curb Opioid Use, SPR Therapeutics Reveals     1/6/2017
Syndrome Linked To Smoking Weed Spikes In States With Legalized Marijuana     12/30/2016
Drug Industry Hired Dozens Of Officials From The DEA As The Agency Tried To Curb Opioid Abuse     12/29/2016
The 10 Largest Marijuana Companies     12/29/2016
Pfizer (PFE) Gets Letter From U.S. Senators Seek Information On Drug To Treat Opioid Overdoses     12/15/2016
Ecstasy Could Become A Prescription Drug For Mental Health     12/13/2016
Could A Simple HDPE Cap Help Prevent Opioid Overdoses?     12/13/2016

Press Releases
Queensland Bauxite Ltd Cannabis Winter Crop And General Update     8/9/2017
Lexaria Bioscience Corp. (LXRP) Engages NetworkNewsWire For Corporate Communications Solutions     8/7/2017
7th Peer-Reviewed Study Published In The Last 7 Months Validates Value Of Proove Biosciences Medicine Technology     8/2/2017
NEMUS Bioscience Announces Presentation Of NB2111 Analgesic And Anti-Addiction Data At NIH-Sponsored Cannabinoid Conference     8/2/2017
Amygdala Initiates Phase Ib Clinical Study Of ANS-6637, The First-In-Class Selective ALDH2 Inhibitor In Development As A Treatment For Substance Use Disorder     8/1/2017
Indivior Announces FDA Acceptance With Priority Review Designation Of RBP-6000 Buprenorphine Monthly Depot New Drug Application (NDA) For The Treatment Of Opioid Use Disorder     7/31/2017
FDA's Plan To Lower Nicotine In Cigarettes To Non-Addictive Levels Shines Spotlight On 22nd Century Group, Inc.     7/31/2017
AutoGenomics To Receive 2017 Industry Division Poster Award At AACC Annual Scientific Meeting And Clinical Lab Expo For Opioid Addiction Panel Study     7/31/2017
University of New South Wales Release: World-First Ketamine Trial Shows Promise For Geriatric Depression     7/26/2017
Axsome (AXSM) Announces AXS-06 (Moseic Meloxicam And Esomeprazole) Meets Primary Endpoint In Phase I Clinical Trial     7/25/2017
Opiant Pharma Announces Phase I Data For OPNT002 In Development For The Treatment Of Alcohol Use Disorder     7/19/2017
Bay Area's Nektar Therapeutics (NKTR) Comes Back With Impressive Opiod Addiction Study Data     7/18/2017
Minneapolis Medical Research Foundation Selects AVISTA Pharma To Support Development Of An Opioid Addiction Vaccine     7/13/2017
Protext Pharma (TXTM) CEO Discusses South Africa Cannabis License     7/13/2017
Elite Pharma (ELI) Reports Topline Results From A Pivotal Fed Bioequivalence Study For SequestOx     7/10/2017

//-->